High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts

Abstract Background Considering that pediatric high-grade gliomas (HGGs) are biologically distinct from their adult counterparts, the objective of this study was to define the landscape of HGGs in adolescents and young adults (AYAs). Methods We performed a multicentric retrospective study of 112 AYA...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuro-oncology (Charlottesville, Va.) Va.), 2020-08, Vol.22 (8), p.1190-1202
Hauptverfasser: Roux, Alexandre, Pallud, Johan, Saffroy, Raphaël, Edjlali-Goujon, Myriam, Debily, Marie-Anne, Boddaert, Nathalie, Sanson, Marc, Puget, Stéphanie, Knafo, Steven, Adam, Clovis, Faillot, Thierry, Cazals-Hatem, Dominique, Mandonnet, Emmanuel, Polivka, Marc, Dorfmüller, Georges, Dauta, Aurélie, Desplanques, Mathilde, Gareton, Albane, Pages, Mélanie, Tauziede-Espariat, Arnault, Grill, Jacques, Bourdeaut, Franck, Doz, François, Dhermain, Frédéric, Mokhtari, Karima, Chretien, Fabrice, Figarella-Branger, Dominique, Varlet, Pascale
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1202
container_issue 8
container_start_page 1190
container_title Neuro-oncology (Charlottesville, Va.)
container_volume 22
creator Roux, Alexandre
Pallud, Johan
Saffroy, Raphaël
Edjlali-Goujon, Myriam
Debily, Marie-Anne
Boddaert, Nathalie
Sanson, Marc
Puget, Stéphanie
Knafo, Steven
Adam, Clovis
Faillot, Thierry
Cazals-Hatem, Dominique
Mandonnet, Emmanuel
Polivka, Marc
Dorfmüller, Georges
Dauta, Aurélie
Desplanques, Mathilde
Gareton, Albane
Pages, Mélanie
Tauziede-Espariat, Arnault
Grill, Jacques
Bourdeaut, Franck
Doz, François
Dhermain, Frédéric
Mokhtari, Karima
Chretien, Fabrice
Figarella-Branger, Dominique
Varlet, Pascale
description Abstract Background Considering that pediatric high-grade gliomas (HGGs) are biologically distinct from their adult counterparts, the objective of this study was to define the landscape of HGGs in adolescents and young adults (AYAs). Methods We performed a multicentric retrospective study of 112 AYAs from adult and pediatric Ile-de-France neurosurgical units, treated between 1998 and 2013 to analyze their clinicoradiological and histomolecular profiles. The inclusion criteria were age between 15 and 25 years, histopathological HGG diagnosis, available clinical data, and preoperative and follow-up MRI. MRI and tumoral samples were centrally reviewed. Immunohistochemistry and complementary molecular techniques such as targeted/next-generation sequencing, whole exome sequencing, and DNA-methylation analyses were performed to achieve an integrated diagnosis according to the 2016 World Health Organization (WHO) classification. Results Based on 80 documented AYA patients, HGGs constitute heterogeneous clinicopathological and molecular groups, with a predominant representation of pediatric subtypes (histone H3-mutants, 40%) but also adult subtypes (isocitrate dehydrogenase [IDH] mutants, 28%) characterized by the rarity of oligodendrogliomas, IDH mutants, and 1p/19q codeletion and the relative high frequency of “rare adult IDH mutations” (20%). H3G34-mutants (14%) represent the most specific subgroup in AYAs. In the H3K27-mutant subgroup, non-brainstem diffuse midline gliomas are more frequent (66.7%) than diffuse intrinsic pontine gliomas (23.8%), contrary to what is observed in children. We found that WHO grade has no prognostic value, but molecular subgrouping has major prognostic importance. Conclusions HGGs in AYAs could benefit from a specific classification, driven by molecular subtyping rather than age group. Collaborative efforts are needed from pediatric and adult neuro-oncology teams to improve the management of HGGs in AYAs.
doi_str_mv 10.1093/neuonc/noaa024
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7594566</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/neuonc/noaa024</oup_id><sourcerecordid>2352052200</sourcerecordid><originalsourceid>FETCH-LOGICAL-c458t-e46e50f7f7cf95850825d8d49327c422cfef539e06f2dac116dab991023f19343</originalsourceid><addsrcrecordid>eNqFkb1v1TAUxS0EoqWwMqKMdEjrjziJF6SqojykJ7HAbLn2dWLk2MFOKnXuP45f8ygfC4Plq-tzfvb1QegtwRcEC3YZYI1BX4aoFKbNM3RKOGU179v2-WNN656T7gS9yvk7xpTwlrxEJ4xiyjvan6KHnRvGekjKQDV4FyeVKxcqZaKHrCEsuVLBVPdxDUPprr40xmLxZS2lykucilSvXqXKOGshQdCQK5viVC0juLTZHjEzGKeW5HSlC3CBNKu05NfohVU-w5vjfoa-3Xz8er2r918-fb6-2te64f1SQ9MCx7aznbaC9xz3lJveNILRTjeUaguWMwG4tdQoTUhr1K0QBFNmiWANO0MfNu683k5gDtMl5eWc3KTSvYzKyb9PghvlEO9kx0XD27YAzjfA-I9td7WXhx5mGIueNXekaN8fL0vxxwp5kZMrH-q9ChDXLCnjFJd8MC7Si02qU8w5gX1iEywPKcstZXlMuRje_TnIk_xXrL8fGtf5f7CfB763Uw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2352052200</pqid></control><display><type>article</type><title>High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Roux, Alexandre ; Pallud, Johan ; Saffroy, Raphaël ; Edjlali-Goujon, Myriam ; Debily, Marie-Anne ; Boddaert, Nathalie ; Sanson, Marc ; Puget, Stéphanie ; Knafo, Steven ; Adam, Clovis ; Faillot, Thierry ; Cazals-Hatem, Dominique ; Mandonnet, Emmanuel ; Polivka, Marc ; Dorfmüller, Georges ; Dauta, Aurélie ; Desplanques, Mathilde ; Gareton, Albane ; Pages, Mélanie ; Tauziede-Espariat, Arnault ; Grill, Jacques ; Bourdeaut, Franck ; Doz, François ; Dhermain, Frédéric ; Mokhtari, Karima ; Chretien, Fabrice ; Figarella-Branger, Dominique ; Varlet, Pascale</creator><creatorcontrib>Roux, Alexandre ; Pallud, Johan ; Saffroy, Raphaël ; Edjlali-Goujon, Myriam ; Debily, Marie-Anne ; Boddaert, Nathalie ; Sanson, Marc ; Puget, Stéphanie ; Knafo, Steven ; Adam, Clovis ; Faillot, Thierry ; Cazals-Hatem, Dominique ; Mandonnet, Emmanuel ; Polivka, Marc ; Dorfmüller, Georges ; Dauta, Aurélie ; Desplanques, Mathilde ; Gareton, Albane ; Pages, Mélanie ; Tauziede-Espariat, Arnault ; Grill, Jacques ; Bourdeaut, Franck ; Doz, François ; Dhermain, Frédéric ; Mokhtari, Karima ; Chretien, Fabrice ; Figarella-Branger, Dominique ; Varlet, Pascale</creatorcontrib><description>Abstract Background Considering that pediatric high-grade gliomas (HGGs) are biologically distinct from their adult counterparts, the objective of this study was to define the landscape of HGGs in adolescents and young adults (AYAs). Methods We performed a multicentric retrospective study of 112 AYAs from adult and pediatric Ile-de-France neurosurgical units, treated between 1998 and 2013 to analyze their clinicoradiological and histomolecular profiles. The inclusion criteria were age between 15 and 25 years, histopathological HGG diagnosis, available clinical data, and preoperative and follow-up MRI. MRI and tumoral samples were centrally reviewed. Immunohistochemistry and complementary molecular techniques such as targeted/next-generation sequencing, whole exome sequencing, and DNA-methylation analyses were performed to achieve an integrated diagnosis according to the 2016 World Health Organization (WHO) classification. Results Based on 80 documented AYA patients, HGGs constitute heterogeneous clinicopathological and molecular groups, with a predominant representation of pediatric subtypes (histone H3-mutants, 40%) but also adult subtypes (isocitrate dehydrogenase [IDH] mutants, 28%) characterized by the rarity of oligodendrogliomas, IDH mutants, and 1p/19q codeletion and the relative high frequency of “rare adult IDH mutations” (20%). H3G34-mutants (14%) represent the most specific subgroup in AYAs. In the H3K27-mutant subgroup, non-brainstem diffuse midline gliomas are more frequent (66.7%) than diffuse intrinsic pontine gliomas (23.8%), contrary to what is observed in children. We found that WHO grade has no prognostic value, but molecular subgrouping has major prognostic importance. Conclusions HGGs in AYAs could benefit from a specific classification, driven by molecular subtyping rather than age group. Collaborative efforts are needed from pediatric and adult neuro-oncology teams to improve the management of HGGs in AYAs.</description><identifier>ISSN: 1522-8517</identifier><identifier>EISSN: 1523-5866</identifier><identifier>DOI: 10.1093/neuonc/noaa024</identifier><identifier>PMID: 32025728</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Adolescent ; Adult ; Age Factors ; Biochemistry, Molecular Biology ; Brain Neoplasms - genetics ; Brain Neoplasms - pathology ; Cancer ; Female ; Genomics ; Glioma - enzymology ; Glioma - genetics ; Glioma - pathology ; Human health and pathology ; Humans ; Isocitrate Dehydrogenase - genetics ; Life Sciences ; Male ; Mutation ; Neoplasm Grading ; Neurobiology ; Neurons and Cognition ; Oligodendroglioma - enzymology ; Oligodendroglioma - genetics ; Oligodendroglioma - pathology ; Pediatric Neuro-Oncology ; Retrospective Studies ; Tissues and Organs ; Young Adult</subject><ispartof>Neuro-oncology (Charlottesville, Va.), 2020-08, Vol.22 (8), p.1190-1202</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020</rights><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c458t-e46e50f7f7cf95850825d8d49327c422cfef539e06f2dac116dab991023f19343</citedby><cites>FETCH-LOGICAL-c458t-e46e50f7f7cf95850825d8d49327c422cfef539e06f2dac116dab991023f19343</cites><orcidid>0000-0002-1652-9844 ; 0000-0002-3650-8581 ; 0000-0003-0991-7774 ; 0000-0002-3604-887X ; 0000-0002-8164-1517 ; 0000-0002-1813-8476 ; 0000-0003-0230-9282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594566/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594566/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,1578,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32025728$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03009834$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Roux, Alexandre</creatorcontrib><creatorcontrib>Pallud, Johan</creatorcontrib><creatorcontrib>Saffroy, Raphaël</creatorcontrib><creatorcontrib>Edjlali-Goujon, Myriam</creatorcontrib><creatorcontrib>Debily, Marie-Anne</creatorcontrib><creatorcontrib>Boddaert, Nathalie</creatorcontrib><creatorcontrib>Sanson, Marc</creatorcontrib><creatorcontrib>Puget, Stéphanie</creatorcontrib><creatorcontrib>Knafo, Steven</creatorcontrib><creatorcontrib>Adam, Clovis</creatorcontrib><creatorcontrib>Faillot, Thierry</creatorcontrib><creatorcontrib>Cazals-Hatem, Dominique</creatorcontrib><creatorcontrib>Mandonnet, Emmanuel</creatorcontrib><creatorcontrib>Polivka, Marc</creatorcontrib><creatorcontrib>Dorfmüller, Georges</creatorcontrib><creatorcontrib>Dauta, Aurélie</creatorcontrib><creatorcontrib>Desplanques, Mathilde</creatorcontrib><creatorcontrib>Gareton, Albane</creatorcontrib><creatorcontrib>Pages, Mélanie</creatorcontrib><creatorcontrib>Tauziede-Espariat, Arnault</creatorcontrib><creatorcontrib>Grill, Jacques</creatorcontrib><creatorcontrib>Bourdeaut, Franck</creatorcontrib><creatorcontrib>Doz, François</creatorcontrib><creatorcontrib>Dhermain, Frédéric</creatorcontrib><creatorcontrib>Mokhtari, Karima</creatorcontrib><creatorcontrib>Chretien, Fabrice</creatorcontrib><creatorcontrib>Figarella-Branger, Dominique</creatorcontrib><creatorcontrib>Varlet, Pascale</creatorcontrib><title>High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts</title><title>Neuro-oncology (Charlottesville, Va.)</title><addtitle>Neuro Oncol</addtitle><description>Abstract Background Considering that pediatric high-grade gliomas (HGGs) are biologically distinct from their adult counterparts, the objective of this study was to define the landscape of HGGs in adolescents and young adults (AYAs). Methods We performed a multicentric retrospective study of 112 AYAs from adult and pediatric Ile-de-France neurosurgical units, treated between 1998 and 2013 to analyze their clinicoradiological and histomolecular profiles. The inclusion criteria were age between 15 and 25 years, histopathological HGG diagnosis, available clinical data, and preoperative and follow-up MRI. MRI and tumoral samples were centrally reviewed. Immunohistochemistry and complementary molecular techniques such as targeted/next-generation sequencing, whole exome sequencing, and DNA-methylation analyses were performed to achieve an integrated diagnosis according to the 2016 World Health Organization (WHO) classification. Results Based on 80 documented AYA patients, HGGs constitute heterogeneous clinicopathological and molecular groups, with a predominant representation of pediatric subtypes (histone H3-mutants, 40%) but also adult subtypes (isocitrate dehydrogenase [IDH] mutants, 28%) characterized by the rarity of oligodendrogliomas, IDH mutants, and 1p/19q codeletion and the relative high frequency of “rare adult IDH mutations” (20%). H3G34-mutants (14%) represent the most specific subgroup in AYAs. In the H3K27-mutant subgroup, non-brainstem diffuse midline gliomas are more frequent (66.7%) than diffuse intrinsic pontine gliomas (23.8%), contrary to what is observed in children. We found that WHO grade has no prognostic value, but molecular subgrouping has major prognostic importance. Conclusions HGGs in AYAs could benefit from a specific classification, driven by molecular subtyping rather than age group. Collaborative efforts are needed from pediatric and adult neuro-oncology teams to improve the management of HGGs in AYAs.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Biochemistry, Molecular Biology</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain Neoplasms - pathology</subject><subject>Cancer</subject><subject>Female</subject><subject>Genomics</subject><subject>Glioma - enzymology</subject><subject>Glioma - genetics</subject><subject>Glioma - pathology</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Isocitrate Dehydrogenase - genetics</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Mutation</subject><subject>Neoplasm Grading</subject><subject>Neurobiology</subject><subject>Neurons and Cognition</subject><subject>Oligodendroglioma - enzymology</subject><subject>Oligodendroglioma - genetics</subject><subject>Oligodendroglioma - pathology</subject><subject>Pediatric Neuro-Oncology</subject><subject>Retrospective Studies</subject><subject>Tissues and Organs</subject><subject>Young Adult</subject><issn>1522-8517</issn><issn>1523-5866</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkb1v1TAUxS0EoqWwMqKMdEjrjziJF6SqojykJ7HAbLn2dWLk2MFOKnXuP45f8ygfC4Plq-tzfvb1QegtwRcEC3YZYI1BX4aoFKbNM3RKOGU179v2-WNN656T7gS9yvk7xpTwlrxEJ4xiyjvan6KHnRvGekjKQDV4FyeVKxcqZaKHrCEsuVLBVPdxDUPprr40xmLxZS2lykucilSvXqXKOGshQdCQK5viVC0juLTZHjEzGKeW5HSlC3CBNKu05NfohVU-w5vjfoa-3Xz8er2r918-fb6-2te64f1SQ9MCx7aznbaC9xz3lJveNILRTjeUaguWMwG4tdQoTUhr1K0QBFNmiWANO0MfNu683k5gDtMl5eWc3KTSvYzKyb9PghvlEO9kx0XD27YAzjfA-I9td7WXhx5mGIueNXekaN8fL0vxxwp5kZMrH-q9ChDXLCnjFJd8MC7Si02qU8w5gX1iEywPKcstZXlMuRje_TnIk_xXrL8fGtf5f7CfB763Uw</recordid><startdate>20200817</startdate><enddate>20200817</enddate><creator>Roux, Alexandre</creator><creator>Pallud, Johan</creator><creator>Saffroy, Raphaël</creator><creator>Edjlali-Goujon, Myriam</creator><creator>Debily, Marie-Anne</creator><creator>Boddaert, Nathalie</creator><creator>Sanson, Marc</creator><creator>Puget, Stéphanie</creator><creator>Knafo, Steven</creator><creator>Adam, Clovis</creator><creator>Faillot, Thierry</creator><creator>Cazals-Hatem, Dominique</creator><creator>Mandonnet, Emmanuel</creator><creator>Polivka, Marc</creator><creator>Dorfmüller, Georges</creator><creator>Dauta, Aurélie</creator><creator>Desplanques, Mathilde</creator><creator>Gareton, Albane</creator><creator>Pages, Mélanie</creator><creator>Tauziede-Espariat, Arnault</creator><creator>Grill, Jacques</creator><creator>Bourdeaut, Franck</creator><creator>Doz, François</creator><creator>Dhermain, Frédéric</creator><creator>Mokhtari, Karima</creator><creator>Chretien, Fabrice</creator><creator>Figarella-Branger, Dominique</creator><creator>Varlet, Pascale</creator><general>Oxford University Press</general><general>Oxford University Press (OUP)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1652-9844</orcidid><orcidid>https://orcid.org/0000-0002-3650-8581</orcidid><orcidid>https://orcid.org/0000-0003-0991-7774</orcidid><orcidid>https://orcid.org/0000-0002-3604-887X</orcidid><orcidid>https://orcid.org/0000-0002-8164-1517</orcidid><orcidid>https://orcid.org/0000-0002-1813-8476</orcidid><orcidid>https://orcid.org/0000-0003-0230-9282</orcidid></search><sort><creationdate>20200817</creationdate><title>High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts</title><author>Roux, Alexandre ; Pallud, Johan ; Saffroy, Raphaël ; Edjlali-Goujon, Myriam ; Debily, Marie-Anne ; Boddaert, Nathalie ; Sanson, Marc ; Puget, Stéphanie ; Knafo, Steven ; Adam, Clovis ; Faillot, Thierry ; Cazals-Hatem, Dominique ; Mandonnet, Emmanuel ; Polivka, Marc ; Dorfmüller, Georges ; Dauta, Aurélie ; Desplanques, Mathilde ; Gareton, Albane ; Pages, Mélanie ; Tauziede-Espariat, Arnault ; Grill, Jacques ; Bourdeaut, Franck ; Doz, François ; Dhermain, Frédéric ; Mokhtari, Karima ; Chretien, Fabrice ; Figarella-Branger, Dominique ; Varlet, Pascale</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c458t-e46e50f7f7cf95850825d8d49327c422cfef539e06f2dac116dab991023f19343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Biochemistry, Molecular Biology</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain Neoplasms - pathology</topic><topic>Cancer</topic><topic>Female</topic><topic>Genomics</topic><topic>Glioma - enzymology</topic><topic>Glioma - genetics</topic><topic>Glioma - pathology</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Isocitrate Dehydrogenase - genetics</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Mutation</topic><topic>Neoplasm Grading</topic><topic>Neurobiology</topic><topic>Neurons and Cognition</topic><topic>Oligodendroglioma - enzymology</topic><topic>Oligodendroglioma - genetics</topic><topic>Oligodendroglioma - pathology</topic><topic>Pediatric Neuro-Oncology</topic><topic>Retrospective Studies</topic><topic>Tissues and Organs</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roux, Alexandre</creatorcontrib><creatorcontrib>Pallud, Johan</creatorcontrib><creatorcontrib>Saffroy, Raphaël</creatorcontrib><creatorcontrib>Edjlali-Goujon, Myriam</creatorcontrib><creatorcontrib>Debily, Marie-Anne</creatorcontrib><creatorcontrib>Boddaert, Nathalie</creatorcontrib><creatorcontrib>Sanson, Marc</creatorcontrib><creatorcontrib>Puget, Stéphanie</creatorcontrib><creatorcontrib>Knafo, Steven</creatorcontrib><creatorcontrib>Adam, Clovis</creatorcontrib><creatorcontrib>Faillot, Thierry</creatorcontrib><creatorcontrib>Cazals-Hatem, Dominique</creatorcontrib><creatorcontrib>Mandonnet, Emmanuel</creatorcontrib><creatorcontrib>Polivka, Marc</creatorcontrib><creatorcontrib>Dorfmüller, Georges</creatorcontrib><creatorcontrib>Dauta, Aurélie</creatorcontrib><creatorcontrib>Desplanques, Mathilde</creatorcontrib><creatorcontrib>Gareton, Albane</creatorcontrib><creatorcontrib>Pages, Mélanie</creatorcontrib><creatorcontrib>Tauziede-Espariat, Arnault</creatorcontrib><creatorcontrib>Grill, Jacques</creatorcontrib><creatorcontrib>Bourdeaut, Franck</creatorcontrib><creatorcontrib>Doz, François</creatorcontrib><creatorcontrib>Dhermain, Frédéric</creatorcontrib><creatorcontrib>Mokhtari, Karima</creatorcontrib><creatorcontrib>Chretien, Fabrice</creatorcontrib><creatorcontrib>Figarella-Branger, Dominique</creatorcontrib><creatorcontrib>Varlet, Pascale</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roux, Alexandre</au><au>Pallud, Johan</au><au>Saffroy, Raphaël</au><au>Edjlali-Goujon, Myriam</au><au>Debily, Marie-Anne</au><au>Boddaert, Nathalie</au><au>Sanson, Marc</au><au>Puget, Stéphanie</au><au>Knafo, Steven</au><au>Adam, Clovis</au><au>Faillot, Thierry</au><au>Cazals-Hatem, Dominique</au><au>Mandonnet, Emmanuel</au><au>Polivka, Marc</au><au>Dorfmüller, Georges</au><au>Dauta, Aurélie</au><au>Desplanques, Mathilde</au><au>Gareton, Albane</au><au>Pages, Mélanie</au><au>Tauziede-Espariat, Arnault</au><au>Grill, Jacques</au><au>Bourdeaut, Franck</au><au>Doz, François</au><au>Dhermain, Frédéric</au><au>Mokhtari, Karima</au><au>Chretien, Fabrice</au><au>Figarella-Branger, Dominique</au><au>Varlet, Pascale</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts</atitle><jtitle>Neuro-oncology (Charlottesville, Va.)</jtitle><addtitle>Neuro Oncol</addtitle><date>2020-08-17</date><risdate>2020</risdate><volume>22</volume><issue>8</issue><spage>1190</spage><epage>1202</epage><pages>1190-1202</pages><issn>1522-8517</issn><eissn>1523-5866</eissn><abstract>Abstract Background Considering that pediatric high-grade gliomas (HGGs) are biologically distinct from their adult counterparts, the objective of this study was to define the landscape of HGGs in adolescents and young adults (AYAs). Methods We performed a multicentric retrospective study of 112 AYAs from adult and pediatric Ile-de-France neurosurgical units, treated between 1998 and 2013 to analyze their clinicoradiological and histomolecular profiles. The inclusion criteria were age between 15 and 25 years, histopathological HGG diagnosis, available clinical data, and preoperative and follow-up MRI. MRI and tumoral samples were centrally reviewed. Immunohistochemistry and complementary molecular techniques such as targeted/next-generation sequencing, whole exome sequencing, and DNA-methylation analyses were performed to achieve an integrated diagnosis according to the 2016 World Health Organization (WHO) classification. Results Based on 80 documented AYA patients, HGGs constitute heterogeneous clinicopathological and molecular groups, with a predominant representation of pediatric subtypes (histone H3-mutants, 40%) but also adult subtypes (isocitrate dehydrogenase [IDH] mutants, 28%) characterized by the rarity of oligodendrogliomas, IDH mutants, and 1p/19q codeletion and the relative high frequency of “rare adult IDH mutations” (20%). H3G34-mutants (14%) represent the most specific subgroup in AYAs. In the H3K27-mutant subgroup, non-brainstem diffuse midline gliomas are more frequent (66.7%) than diffuse intrinsic pontine gliomas (23.8%), contrary to what is observed in children. We found that WHO grade has no prognostic value, but molecular subgrouping has major prognostic importance. Conclusions HGGs in AYAs could benefit from a specific classification, driven by molecular subtyping rather than age group. Collaborative efforts are needed from pediatric and adult neuro-oncology teams to improve the management of HGGs in AYAs.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>32025728</pmid><doi>10.1093/neuonc/noaa024</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-1652-9844</orcidid><orcidid>https://orcid.org/0000-0002-3650-8581</orcidid><orcidid>https://orcid.org/0000-0003-0991-7774</orcidid><orcidid>https://orcid.org/0000-0002-3604-887X</orcidid><orcidid>https://orcid.org/0000-0002-8164-1517</orcidid><orcidid>https://orcid.org/0000-0002-1813-8476</orcidid><orcidid>https://orcid.org/0000-0003-0230-9282</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1522-8517
ispartof Neuro-oncology (Charlottesville, Va.), 2020-08, Vol.22 (8), p.1190-1202
issn 1522-8517
1523-5866
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7594566
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adolescent
Adult
Age Factors
Biochemistry, Molecular Biology
Brain Neoplasms - genetics
Brain Neoplasms - pathology
Cancer
Female
Genomics
Glioma - enzymology
Glioma - genetics
Glioma - pathology
Human health and pathology
Humans
Isocitrate Dehydrogenase - genetics
Life Sciences
Male
Mutation
Neoplasm Grading
Neurobiology
Neurons and Cognition
Oligodendroglioma - enzymology
Oligodendroglioma - genetics
Oligodendroglioma - pathology
Pediatric Neuro-Oncology
Retrospective Studies
Tissues and Organs
Young Adult
title High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T01%3A00%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-grade%20gliomas%20in%20adolescents%20and%20young%20adults%20highlight%20histomolecular%20differences%20from%20their%20adult%20and%20pediatric%20counterparts&rft.jtitle=Neuro-oncology%20(Charlottesville,%20Va.)&rft.au=Roux,%20Alexandre&rft.date=2020-08-17&rft.volume=22&rft.issue=8&rft.spage=1190&rft.epage=1202&rft.pages=1190-1202&rft.issn=1522-8517&rft.eissn=1523-5866&rft_id=info:doi/10.1093/neuonc/noaa024&rft_dat=%3Cproquest_pubme%3E2352052200%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2352052200&rft_id=info:pmid/32025728&rft_oup_id=10.1093/neuonc/noaa024&rfr_iscdi=true